SGRY — Surgery Partners Cashflow Statement
0.000.00%
Last trade - 00:00- $3.12bn
- $7.07bn
- $2.74bn
- 77
- 58
- 43
- 62
Annual cashflow statement for Surgery Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 45.1 | 1.3 | 70.7 | 87 | 135 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 68.2 | 96.8 | 57.8 | 95.8 | 106 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -68.8 | 75.9 | -149 | -161 | -63.5 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 130 | 247 | 87.1 | 159 | 294 |
| Capital Expenditures | -73.6 | -42.9 | -57.6 | -80.6 | -88.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -11.6 | -45.5 | -274 | -227 | -137 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -85.2 | -88.4 | -332 | -308 | -226 |
| Financing Cash Flow Items | -134 | -146 | -217 | -185 | -175 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -136 | 66.7 | 316 | 42.1 | -155 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -91.6 | 225 | 71.7 | -107 | -87 |